Evidence map›Paper›PMID 42604222›Full record

ArticleStructural heart : the journal of the Heart Team2026

Complete Versus Incomplete Revascularization in Patients With Severe Aortic Stenosis Undergoing Complex, High-Risk PCI: Insights From the ASCoP Registry.

Francesco Tartaglia, Antonio Mangieri, Andrea R Munafò, Damiano Regazzoli, Giuseppe Esposito, Francesco Soriano, Ketina Arslani, Stephanie Brunner, Sarah Verhemel, Andrea Buono and 27 more

Abstract read
In one paragraph

Article in Structural heart : the journal of the Heart Team, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Francesco TartagliaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Antonio MangieriDivision of Cardiology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Andrea R MunafòInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Damiano RegazzoliDivision of Cardiology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Giuseppe EspositoInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Francesco SorianoInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Ketina ArslaniThe Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Stephanie BrunnerHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Sarah VerhemelDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Andrea BuonoInterventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Mattia SquillaceDivision of Cardiology, IRCCS Policlinico S. Donato, Milan, Italy.
José Luis Díez GilDepartment of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Andrea ScottiMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Alessandro Mandurino-MirizziInterventional Cardiology Unit, IRCCS University Hospital of Bologna, Policlinico S. Orsola, Bologna, Italy.
David BauerDepartment of Cardiology, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, Prague, Czech Republic.
Pablo CodnerDepartment of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
Kerstin PiaydaDivision of Cardiology, CardioVascular Center Frankfurt (CVC), Frankfurt, Germany.
Italo PortoDepartment of Internal Medicine (DIMI), University of Genoa, Genoa, Italy.
Stefano NavaInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Matteo MaurinaInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Mauro GittoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Horst SievertDivision of Cardiology, CardioVascular Center Frankfurt (CVC), Frankfurt, Germany.
Ran KornowskiDepartment of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
Petr ToušekDepartment of Cardiology, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, Prague, Czech Republic.
Marco MussardoCardiology Department, Vito Fazzi Hospital, Lecce, Italy.
Giulio StefaniniDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Azeem LatibMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Jorge Sanz SanchezDepartment of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Diego MaffeoInterventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Francesco BedogniDivision of Cardiology, IRCCS Policlinico S. Donato, Milan, Italy.
Bernhard ReimersDivision of Cardiology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Nicholas Van MieghemDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Francesco SaiaInterventional Cardiology Unit, IRCCS University Hospital of Bologna, Policlinico S. Orsola, Bologna, Italy.
Stefan ToggweilerHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Jacopo A OregliaInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Ole De BackerThe Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Claudio MontaltoInterventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Complex coronary artery disease frequently coexists with severe aortic stenosis. The prognostic impact of complete revascularization (CR) versus incomplete revascularization (IR) in patients undergoing complex and/or high-risk indicated percutaneous coronary intervention (CHIP) and transcatheter aortic valve implantation (TAVI) remains unclear. Methods: We analyzed 550 patients who underwent CHIP and transfemoral TAVI between 2013 and 2023 at 14 international centers. Patients were stratified by completeness of revascularization. The primary endpoint was a composite of all-cause death and unplanned cardiovascular (CV) hospitalization at 1 year. Results: CR was achieved in 299 patients (54.4%). Patients with IR more frequently had three-vessel disease, bifurcation lesions, left main disease, and need for mechanical support. Balloon-expandable valves were more frequently implanted in the CR cohort. Short-term outcomes were similar in the two groups. At 1 year, the incidence of the primary endpoint did not differ significantly between CR and IR groups (20.1 vs. 27.3%, hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.49-1.07). CV rehospitalizations were significantly reduced in the CR group (14.8 vs. 22.8%, HR 0.61, 95% CI 0.38-0.97) even after multivariable adjustment and excluding hospitalizations for repeat revascularization. Conclusions: In patients undergoing CHIP and TAVI, CR was associated with a reduction in CV hospitalizations. Further studies are needed to confirm this finding.

Indexed as

Aortic stenosis (AS)Complete revascularization (CR)Complex and/or high-risk indicated procedure PCI (CHIP)Percutaneous coronary intervention (PCI)Transcatheter aortic valve implantation (TAVI)

Identifiers

PMID42604222
PMCPMC13476877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.